Home
HN

Hiromu Nakajima

1.1K
46
16

About Member

Bio

Currently, I work as the Facility Director of Matsubara Tokushu-en, a modern healthcare facility for the elderly. Before that I was the Chief Medical Officer (CMO) at Nippon Shinyaku, a Japan based R&D pharmaceutical company. The role covered leadership in medical governance, medical authority, safety advising, science and ethics review, and patient insight/PPI review, as well as supervisising clinical development programs. The basis of skill and knowledge as pharma physician is developed while in GSK. The achievement is marked as over 30 approval/launces of new medicines, change management facillitation and team buidlings. Originally, I spent my fruitful years in the highly academic activities in the university and the medical center. In such research activities, I achieved varieties of the innovative milestones of medical science in those years. Thise inculde biochemistry, immunology, molecular biology, systems biology and bioethocs. My important face as a physician was nurtured during a leader position in the management of the Department of Endocrinology and Metabolism at the University Hospital and the chief medical director at the Medical Center. Up to current, more than a quarter of a century I also have been dedicated to the education activities of bioethics for young medical and nursing students at several universities. My overall picture can be an ethical and scientific leader at the medical and pharmaceutical environment.

Education

  • Graduate School of Medicine Osaka University
    Degree PhD degree
    Field of Study Internal Medicine
    Start Date 01/1982
    End Date 01/1986
  • Osaka University
    Degree MD degree
    Field of Study Faculty of Medicine
    Start Date 01/1976
    End Date 01/1982

Experience

NS

Chief Medical Officer

Nippon Shinyaku (Japan) β€’

01/2022 – 01/2025 β€’

Research and Development

NS

Corporate Officer/ SVP-Chief Medical Officer

Nippon Shinyaku (Japan) β€’

01/2018 – 01/2022 β€’

Research and Development

NS

Corporate Officer/ SVP-Chief Medical Officer/ Head of Medical

Nippon Shinyaku (Japan) β€’

01/2017 – 01/2018 β€’

Medical Supervisory Division

NS

VP-Chief Medical Officer

Nippon Shinyaku (Japan) β€’

01/2017 – 01/2017 β€’

Research and Development

GlaxoSmithKline

Corporate Officer-Head of Medicines Development

GlaxoSmithKline β€’

01/2013 – 01/2016 β€’

Research and Development

GlaxoSmithKline

Corporate Officer/ VP-Head of Medicines Development

GlaxoSmithKline β€’

01/2016 – 01/2016 β€’

Research and Development

FR

Consultant at Multitask Company, Ltd.

Freelance β€’

01/2016 – 01/2016 β€’

GlaxoSmithKline

Director of Clinical Research

GlaxoSmithKline β€’

01/2007 – 01/2012 β€’

Research and Development

GlaxoSmithKline

Corporate Officer-Director of Clinical Research

GlaxoSmithKline β€’

01/2012 – 01/2012 β€’

Research and Development

GlaxoSmithKline

Special Medical Advisor

GlaxoSmithKline β€’

01/2006 – 01/2007 β€’

Research and Development

OM

Chief Director

Osaka Medical Center for Cancer and Cardiovascular Diseases β€’

01/2005 – 01/2006 β€’

Internal Medicine/ Clinical Investigation

OM

Director

Osaka Medical Center for Cancer and Cardiovascular Diseases β€’

01/2004 – 01/2005 β€’

Internal Medicine/ Clinical Investigation

OM

Deputy Director

Osaka Medical Center for Cancer and Cardiovascular Diseases β€’

01/2000 – 01/2004 β€’

Internal Medicine/ Clinical Investigation

Osaka University

Assistant Professor

Osaka University β€’

01/1993 – 01/2000 β€’

Internal Medicine and Molecular Science

Osaka University

Lecturer

Osaka University β€’

01/2000 – 01/2000 β€’

Internal Medicine and Molecular Science

Osaka University

Staff Physician

Osaka University β€’

01/1986 – 01/1993 β€’

Internal Medicine

Hiromu Nakajima β€” Facility Director/Chief Medical Director | PharmaCountry